BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 19214194)

  • 1. Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines.
    Pollard AJ; Perrett KP; Beverley PC
    Nat Rev Immunol; 2009 Mar; 9(3):213-20. PubMed ID: 19214194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term protection after immunization with protein-polysaccharide conjugate vaccines in infancy.
    Blanchard-Rohner G; Pollard AJ
    Expert Rev Vaccines; 2011 May; 10(5):673-84. PubMed ID: 21604987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conjugated polysaccharide vaccines.
    Ahmad H; Chapnick EK
    Infect Dis Clin North Am; 1999 Mar; 13(1):113-33, vii. PubMed ID: 10198795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune responses to polysaccharides: lessons from humans and mice.
    González-Fernández A; Faro J; Fernández C
    Vaccine; 2008 Jan; 26(3):292-300. PubMed ID: 18160186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenges in immunisation against bacterial infection in children.
    Trück J; Pollard AJ
    Early Hum Dev; 2010 Nov; 86(11):695-701. PubMed ID: 20851537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization of newborns with bacterial conjugate vaccines.
    van den Biggelaar AH; Pomat WS
    Vaccine; 2013 May; 31(21):2525-30. PubMed ID: 22728221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polysaccharide-specific B cell responses to vaccination in humans.
    Mitchell R; Kelly DF; Pollard AJ; Trück J
    Hum Vaccin Immunother; 2014; 10(6):1661-8. PubMed ID: 24632599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactogenicity and immunogenicity of combined vaccines for bacteraemic diseases caused by Haemophilus influenzae type b, meningococci and pneumococci in 24-month-old children.
    Eskola J; Käyhty H; Takala A; Rönnberg PR; Kela E; Peltola H
    Vaccine; 1990 Apr; 8(2):107-10. PubMed ID: 2110703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein conjugate vaccines--how much is enough?
    Obaro SK
    Trends Microbiol; 2001 Aug; 9(8):364-5. PubMed ID: 11519529
    [No Abstract]   [Full Text] [Related]  

  • 10. Conjugate vaccines--a breakthrough in vaccine development.
    Mäkelä PH
    Southeast Asian J Trop Med Public Health; 2003 Jun; 34(2):249-53. PubMed ID: 12971544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic priming to capsular polysaccharide in infants immunized with Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine.
    Weinberg GA; Einhorn MS; Lenoir AA; Granoff PD; Granoff DM
    J Pediatr; 1987 Jul; 111(1):22-7. PubMed ID: 3110388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine.
    Leach A; Twumasi PA; Kumah S; Banya WS; Jaffar S; Forrest BD; Granoff DM; LiButti DE; Carlone GM; Pais LB; Broome CV; Greenwood BM
    J Infect Dis; 1997 Jan; 175(1):200-4. PubMed ID: 8985221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological memory: the role of B cells in long-term protection against invasive bacterial pathogens.
    Kelly DF; Pollard AJ; Moxon ER
    JAMA; 2005 Dec; 294(23):3019-23. PubMed ID: 16414950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine immune responses to Neisseria meningitidis group C capsular polysaccharide and a thymus-dependent toxoid conjugate vaccine.
    Rubinstein LJ; García-Ojeda PA; Michon F; Jennings HJ; Stein KE
    Infect Immun; 1998 Nov; 66(11):5450-6. PubMed ID: 9784556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of protein-conjugate polysaccharide vaccines: an endgame for meningitis?
    Maiden MC
    Philos Trans R Soc Lond B Biol Sci; 2013 Aug; 368(1623):20120147. PubMed ID: 23798695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustaining immunity after immunization against encapsulated bacteria.
    Blanchard-Rohner G; Pollard AJ
    Hum Vaccin; 2008; 4(4):309-12. PubMed ID: 18398302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serologic responses to an Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine in very young Gambian infants.
    Campbell H; Byass P; Ahonkhai VI; Vella PP; Greenwood BM
    Pediatrics; 1990 Jul; 86(1):102-7. PubMed ID: 2113671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers: a randomized controlled trial.
    MacDonald NE; Halperin SA; Law BJ; Forrest B; Danzig LE; Granoff DM
    JAMA; 1998 Nov; 280(19):1685-9. PubMed ID: 9832000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of bacterial polysaccharide immune globulin for the treatment or prevention of Haemophilus influenzae type b and pneumococcal disease.
    Siber GR; Thompson C; Reid GR; Almeido-Hill J; Zacher B; Wolff M; Santosham M
    J Infect Dis; 1992 Jun; 165 Suppl 1():S129-33. PubMed ID: 1588146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemophilus influenzae serotype b vaccine failure: what is the significance of antibody levels?
    Spanjaard L; Rijkers GT
    Clin Infect Dis; 2009 Aug; 49(3):381-2. PubMed ID: 19580417
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.